Abstract
Background and Aims: Insulin secretion is controlled by pancreatic α<sub>2A</sub>-adrenoceptors. Mice lacking α<sub>2A</sub>-adrenoceptors (α<sub>2A</sub>AR<sup>–/–</sup> mice) show hyperinsulinaemia, reduced blood glucose levels and improved glucose tolerance. Methods: In the present study, we used α<sub>2AC</sub>AR<sup>–/–</sup>, α<sub>2C</sub>AR<sup>–/–</sup> and α<sub>2A</sub>AR<sup>–/–</sup> mice and a mouse line with adrenergic cell-specific expression of α<sub>2A</sub>-adrenoceptors (lacking these receptors in non-adrenergic cells), and their wild-type (WT) controls, to assess the glucoregulatory role of the α<sub>2C</sub>-adrenoceptor subtype in vivo. Glucose and insulin tolerance tests were performed and blood glucose and serum insulin levels were determined after fasting and glucose stimulation. Plasma catecholamines were also measured. In addition, the effect of pretreatment with (±)-propranolol was determined in α<sub>2C</sub>AR<sup>–/–</sup> mice. Results: α<sub>2AC</sub>AR<sup>–/–</sup> mice had a similar glucose and insulin phenotype as α<sub>2A</sub>AR<sup>–/–</sup> mice and mice with restored α<sub>2A</sub>-autoreceptors, suggesting that only deletion of postsynaptic α<sub>2A</sub>-adrenoceptors has major effects on glucose disposition. However, α<sub>2AC</sub>AR<sup>–/–</sup> mice were more sensitive to the glucose-lowering effect of insulin than WT mice. This was not observed in α<sub>2A</sub>AR<sup>–/–</sup> mice. The α<sub>2C</sub>AR<sup>–/–</sup> mice showed impaired glucose tolerance that was reversed by pretreatment with (±)-propranolol. No difference in insulin secretion was observed in α<sub>2C</sub>AR<sup>–/–</sup> mice compared with WT animals. Conclusion: The results underline that depletion of postsynaptic pancreatic α<sub>2A</sub>-adrenoceptors has major effects on the regulation of glucose homeostasis in α<sub>2AC</sub>AR<sup>–/–</sup> and α<sub>2A</sub>AR<sup>–/–</sup> mice. Deletion of the α<sub>2C</sub> subtype leads to increased adrenaline secretion and has the potential to increase blood glucose levels via enhanced glycogenolysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.